Company attributes
Venture Capital Firm attributes
Other attributes
Synergy Life Sciences partners aims to fund medical device companies and early-stage medical device with therapeutic components such as biologics and drugs. By adopting a synergistic strategy with business visionaries to build important organizations, Synergy does capital designation with their specialized, clinical and operational mastery.
Synergy centers around young companies in the medical field. This company looks for organizations with expert individuals in their own field and those with engaging, capital-productive, clinically-determined and feasible plans.
Synergy will put part of its assets in Synecor-originated opportunities. Synecor is an exceptionally effective medical incubatee established in 2000 by Richard Stack and Bill Starling, two of Synergy's Managing Directors.